2ND-LOOK LAPAROTOMY IN OVARIAN-CANCER

被引:24
作者
CREASMAN, WT
机构
[1] Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham
[2] Department of Medicine/Division of Hematologic Oncology, Duke University Medical Center, Durham
[3] Cancer Center Biostatistics Department, Duke University Medical Center, Durham
[4] Division of Gynecologic Oncology, Evanston Northwestern Healthcare, Northwestern University Medical School, Chicago
关键词
D O I
10.1006/gyno.1994.1350
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of the second-look laparotomy has become standard management in the patients with ovarian cancer without any objective evidence that it has a major impact on survival. In patients with early-stage disease, data on second-look surgery would suggest that there is very little, if any, benefit in patients who have had optimal full surgical staging and appropriate postoperative therapy. In advanced disease, even if the second-look laparotomy is negative, one-half will develop a recurrence. The role of the second-look laparotomy as a secondary debulking procedure has been suggested by some but appears to be beneficial in only a small subset of patients-less than 10%. In patients being treated on protocol, a second-look laparotomy has become the gold standard for determining effectiveness of a specific treatment being evaluated and would tend to be justified in this group to increase our knowledge and hopefully arrive at a better postsurgical therapy. (C) 1994 Academic Press, Inc.
引用
收藏
页码:S122 / S127
页数:6
相关论文
共 30 条
[1]  
BEREK JS, 1983, OBSTET GYNECOL, V61, P189
[2]   THE PROGNOSTIC AND THERAPEUTIC VALUE OF 2ND-LOOK LAPAROTOMY IN ADVANCED OVARIAN-CANCER [J].
BERTELSEN, K ;
HANSEN, MK ;
PEDERSEN, PH ;
LARSEN, G ;
NYLAND, M ;
JACOBSEN, M ;
ANDERSEN, JE .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1988, 95 (12) :1231-1236
[3]   CANCER STATISTICS, 1994 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T ;
MONTGOMERY, S .
CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) :7-26
[4]   IMPROVED THERAPY WITH CISPLATIN REGIMENS FOR PATIENTS WITH OVARIAN-CARCINOMA (FIGO STAGE-III AND STAGE-IV) AS MEASURED BY SURGICAL END-STAGING (2ND-LOOK OPERATION) [J].
COHEN, CJ ;
GOLDBERG, JD ;
HOLLAND, JF ;
BRUCKNER, HW ;
DEPPE, G ;
GUSBERG, SB ;
WALLACH, RC ;
KABAKOW, B ;
RODIN, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (08) :955-967
[5]   2ND-LOOK LAPAROTOMY IN THE PATIENT WITH MINIMAL RESIDUAL STAGE-III OVARIAN-CANCER (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
CREASMAN, WT ;
GALL, S ;
BUNDY, BN ;
BEECHAM, J ;
MORTEL, R ;
HOMESLEY, HD .
GYNECOLOGIC ONCOLOGY, 1989, 35 (03) :378-382
[6]  
DAUPLAT J, 1986, CANCER, V57, P1627, DOI 10.1002/1097-0142(19860415)57:8<1627::AID-CNCR2820570831>3.0.CO
[7]  
2-D
[8]   2ND-LOOK LAPAROTOMY - CLINICAL CORRELATIONS [J].
FREE, KE ;
WEBB, MJ .
GYNECOLOGIC ONCOLOGY, 1987, 26 (03) :290-297
[9]   THERAPY OF STAGE-III (OPTIMAL) EPITHELIAL CARCINOMA OF THE OVARY WITH MELPHALAN OR MELPHALAN PLUS CORYNEBACTERIUM PARVUM - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
GALL, S ;
BUNDY, B ;
BEECHAM, J ;
WHITNEY, C ;
HOMESLEY, H ;
LIFSHITZ, S ;
ADCOCK, LL .
GYNECOLOGIC ONCOLOGY, 1986, 25 (01) :26-36
[10]   ADVANCED OVARIAN-CANCER - LONG-TERM RESULTS OF TREATMENT WITH INTENSIVE CISPLATIN-BASED CHEMOTHERAPY OF BRIEF DURATION [J].
HAINSWORTH, JD ;
GROSH, WW ;
BURNETT, LS ;
JONES, HW ;
WOLFF, SN ;
GRECO, FA .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :165-170